#1
Which of the following is a common cause of stable narrow-complex tachycardia?
#2
Which of the following rhythms is NOT treated with synchronized cardioversion in ACLS?
#3
Which of the following is NOT a recommended intervention for stable narrow-complex tachycardia in ACLS?
#4
Which medication is NOT commonly used in ACLS for the treatment of pulseless ventricular tachycardia (VT) or ventricular fibrillation (VF)?
#5
What is the primary goal of ACLS during resuscitation efforts?
#6
What is the first step in managing stable narrow-complex tachycardia according to ACLS guidelines?
#7
In ACLS, what is the recommended initial dose of adenosine for treating regular narrow-complex tachycardia?
#8
What is the recommended maximum dose of adenosine for the treatment of stable supraventricular tachycardia (SVT)?
#9
In ACLS, what is the recommended dose of epinephrine for patients with pulseless ventricular tachycardia?
#10
In ACLS, what is the preferred method for confirming the correct placement of an endotracheal tube during resuscitation?
#11
What is the recommended initial energy level for synchronized cardioversion in ACLS for hemodynamically unstable tachycardia?
#12
Which antiarrhythmic medication is typically used in ACLS for pharmacological cardioversion of stable monomorphic ventricular tachycardia?
#13
Which medication is typically used as the first-line therapy for unstable narrow-complex tachycardia in ACLS?
#14
What is the recommended initial dose of amiodarone for the treatment of pulseless ventricular tachycardia (VT) or ventricular fibrillation (VF) in ACLS?
#15